Finance

Lists
AHCO:NASDAQ
Adapthealth Corp
$7.80
+1.04%
(+0.080) 1D
$7.80
0.00% (0.00)
After hours
Closed: Nov 11, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHCO...
Open
$7.65
High
$7.92
Low
$7.64
Mkt. cap
1.06B
Avg. vol.
2.56M
Volume
0.00
52-wk high
$13.43
52-wk low
$5.21
EPS
-$2.97
Beta
1.36
Shares outstanding
136.52M
No. of employees
11K
Open
$7.65
High
$7.92
Low
$7.64
Mkt. cap
1.06B
Avg. vol.
2.56M
Volume
0.00
52-wk high
$13.43
52-wk low
$5.21
EPS
-$2.97
Beta
1.36
Shares outstanding
136.52M
No. of employees
11K
News stories
From web sources and news partners
About Adapthealth Corp
CEO-
Employees10.9K
Founded2012
HeadquartersConshohocken, Pennsylvania, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to AHCO in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AHCO in the last 3 months.
Highest
Current $7.80
$10.00 (+28.21%)
Average
$9.00 (+15.38%)
Lowest
$8.00 (+2.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Reiterated
$8.00
+2.6%
11/05/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$10.00
+28.2%
11/03/2026
Kevin Caliendo
UBS
Buy
Maintained
$9.00
+15.4%
11/04/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$8.00
+2.6%
11/03/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$9.00
+15.4%
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$10.00
+28.2%
09/15/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/09/2026
Jack Slevin
Jefferies
Buy
Upgraded
$13.00
+66.7%
07/21/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
$9.50
+21.8%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
846.29M
679.87M
740.31M
745.65M
Cost of goods sold
661.38M
563.34M
611.86M
609.19M
Cost of revenue
661.38M
563.34M
611.86M
609.19M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
122.54M
114.78M
114.26M
110.31M
Operating expense
132.47M
121.95M
122.21M
119.62M
Total operating expenses
793.85M
685.29M
734.07M
728.82M
Operating income
52.44M
-5.42M
6.24M
16.83M
Other non operating income
726.00K
-
-
-
EBT including unusual items
-97.99M
-31.02M
-165.33M
-184.52M
EBT excluding unusual items
28.72M
-31.02M
-19.97M
-11.77M
Income tax expense
3.54M
-7.16M
-21.23M
-17.49M
Effective tax rate
-3.62%
23.10%
12.84%
9.48%
Other operating expenses
-
-
-
-
Net income
-102.77M
-16.04M
-133.93M
-153.99M
Net profit margin
-12.14%
-2.36%
-18.09%
-20.65%
Earnings per share
0.27
-0.05
-0.07
0.07
Interest and investment income
-
-
-
-
Interest expense
-24.44M
-25.59M
-26.21M
-28.60M
Net interest expenses
-24.44M
-25.59M
-26.21M
-28.60M
Depreciation and amortization charges
9.93M
7.17M
7.95M
9.32M
EBITDA
149.94M
106.09M
131.57M
138.56M
Gain or loss from assets sale
-377.00K
-
-6.27M
-12.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps